Valuation : Highnoon Laboratories Limited

Market Cap 49.32B 178M 153M 144M 131M 246M 16.79B 247M 1.7B 660M 8.61B 668M 653M 27.74B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 49.32B 178M 153M 144M 131M 246M 16.79B 247M 1.7B 660M 8.61B 668M 653M 27.74B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.44x
Free-Float
50.02%
Yield 2026 *
4.83%
Yield 2027 * 5.59%
1 day-0.68%
1 week-2.07%
Current month-0.44%
1 month-4.82%
3 months-4.66%
6 months+4.87%
Current year-8.97%
1 week 921.2
Extreme 921.2
956
1 month 921.2
Extreme 921.2
1,038.99
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2012-09-06
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-2.07%-20.99%+157.98% 178M
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -0.96%+0.94%+23.37%+61.82% 367.85B
Weighted average by Cap. -1.10%+0.55%+36.62%+66.23%

Financials

2026 *2027 *
Net sales 30.4B 110M 94.3M 88.72M 81.05M 152M 10.35B 152M 1.05B 407M 5.31B 412M 403M 17.1B 34.16B 123M 106M 99.71M 91.09M 170M 11.63B 171M 1.18B 457M 5.97B 462M 452M 19.22B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-09-04 PKR 930.78 -0.68% 26,706
26-09-03 PKR 937.18 +1.24% 12,912
26-09-02 PKR 925.66 -0.30% 12,320
26-09-01 PKR 928.47 -0.68% 14,626
26-08-31 PKR 934.86 -1.64% 18,231
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
930.78PKR
Average target price
1,121.00PKR
Spread / Average Target
+20.44%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock